Cargando…

Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery

BACKGROUND: The prognostic utility of cardiac biomarkers, high-sensitivity cardiac troponin I (hs-cTnI) and soluble suppression of tumorigenicity-2 (sST2), in non-cardiac surgery is not well-defined. We evaluated hs-cTnI and sST2 as predictors of 30-day major adverse cardiac events (MACE) in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hyun Suk, Hur, Mina, Yi, Ahram, Kim, Hanah, Kim, Jayoun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820064/ https://www.ncbi.nlm.nih.gov/pubmed/29401554 http://dx.doi.org/10.3343/alm.2018.38.3.204

Ejemplares similares

Soluble Suppression of Tumorigenicity 2 and Echocardiography in Sepsis
por: Yang, Hyun Suk, et al.
Publicado: (2016)

Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis
por: Kim, Hanah, et al.
Publicado: (2017)

Prognostic value of presepsin in adult patients with sepsis: Systematic review and meta-analysis
por: Yang, Hyun Suk, et al.
Publicado: (2018)

Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases
por: Moon, Hee-Won, et al.
Publicado: (2018)

Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement
por: Iannazzo, Francesco, et al.
Publicado: (2022)

Cardiac troponins in intensive care
por: Collinson, Paul, et al.
Publicado: (2005)

Lack of prognostic significance for major adverse cardiac events of soluble suppression of tumorigenicity 2 levels in patients with ST-segment elevation myocardial infarction
por: Kim, Min, et al.
Publicado: (2021)

Soluble ST2 Has a Prognostic Role in Patients With Suspected Sepsis
por: Hur, Mina, et al.
Publicado: (2015)

Prognostic Utility of Soluble Suppression of Tumorigenicity 2 level as a Predictor of Clinical Outcomes in Incident Hemodialysis Patients
por: Seo, Suk Min, et al.
Publicado: (2018)

Reference interval and the role of soluble suppression of tumorigenicity 2 (sST2) in subclinical cardiac dysfunction at health checkups
por: Nah, Eun‐Hee, et al.
Publicado: (2020)

The soluble suppression of tumorigenicity 2 as a biomarker of early cardiac remodeling in bradycardia patients receiving permanent pacemaker therapy
por: Iqbal, Mohammad, et al.
Publicado: (2023)

Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Harada, Yukinori, et al.
Publicado: (2016)

High-sensitive cardiac troponins in patients undergoing cardiac surgery: friend or foe?
por: Wittock, A, et al.
Publicado: (2015)

Effect of Exercise Intensity and Duration on Cardiac Troponin Release
por: Marshall, Lucy, et al.
Publicado: (2020)

Cardiac Troponin I in Patients Undergoing Percutaneous and Surgical Myocardial Revascularization: Comparison of Analytical Methods
por: Vendramini, Sabrina Pacheco do Amaral, et al.
Publicado: (2023)

High-sensitive cardiac troponins and CK-MB concentrations in patients undergoing cardiac surgery
por: Mey, N De, et al.
Publicado: (2015)

Use and Prognostic Implications of Cardiac Troponin in COVID-19
por: De Michieli, Laura, et al.
Publicado: (2022)

Prognostic Value of High-Sensitivity Cardiac Troponin in Women
por: Bisaccia, Giandomenico, et al.
Publicado: (2022)

Use and Prognostic Implications of Cardiac Troponin in COVID-19
por: De Michieli, Laura, et al.
Publicado: (2023)

Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure
por: Gül, İbrahim, et al.
Publicado: (2017)

Cardiac Troponin Elevation and Outcome in Subarachnoid Hemorrhage
por: Zahid, Tehrim, et al.
Publicado: (2020)

Soluble suppression of tumorigenicity 2 is a potential predictor of post-liver transplant renal outcomes
por: Moon, Jong Joo, et al.
Publicado: (2023)

Preoperative cardiac troponin I as a predictor of postoperative cardiac events in patients with end stage renal disease undergoing non-cardiac surgery
por: Park, Bo Eun, et al.
Publicado: (2022)

Absolute Change in High-Sensitivity Cardiac Troponin I at Three Hours After Presentation is Useful for Diagnosing Acute Myocardial Infarction in the Emergency Department
por: Kim, Jong Won, et al.
Publicado: (2020)

Role of cardiac troponin as a prognosticator in critically ill patients
por: Turley, Andrew J, et al.
Publicado: (2005)

Cardiac Troponin I and T as Prognostic Markers in Cats with Hypertrophic Cardiomyopathy
por: Langhorn, R., et al.
Publicado: (2014)

Prognostic Significance of Elevated Cardiac Troponin in Acute Gastrointestinal Bleeding
por: Iqbal, Umair, et al.
Publicado: (2017)

The prognostic role of cardiac troponin in hospitalized COVID-19 patients
por: Tanboğa, Ibrahim Halil, et al.
Publicado: (2021)

Prognostic Value of Cardiac Troponin I in Patients with Ventricular Tachyarrhythmias
por: Akin, Ibrahim, et al.
Publicado: (2022)

Soluble Suppression of Tumorigenicity-2 as a Candidate Prognostic Marker for Stroke: A Systematic Review
por: Ahmadzadeh, Koohyar, et al.
Publicado: (2023)

Postoperative high-sensitivity troponin T as a predictor of sudden cardiac arrest in patients undergoing cardiac surgery
por: Duchnowski, Piotr, et al.
Publicado: (2020)

COVID-19, cardiovascular diseases and cardiac troponins
por: Kim, Chan W, et al.
Publicado: (2021)

Prognostic value of cardiac Troponin I after cardiac surgery: comparison with two different assays
por: Provenchère, S, et al.
Publicado: (2003)

Prognostic value of high-sensitivity cardiac troponin T in patients with endomyocardial-biopsy proven cardiac amyloidosis
por: Qian, Geng, et al.
Publicado: (2014)

Effectiveness of Plasma and Urine Neutrophil Gelatinase-Associated Lipocalin for Predicting Acute Kidney Injury in High-Risk Patients
por: Yi, Ahram, et al.
Publicado: (2021)

Association Between High‐Sensitivity Cardiac Troponin T and Echocardiographic Parameters in Chronic Kidney Disease: Results From the KNOW‐CKD Cohort Study
por: Kang, Eunjeong, et al.
Publicado: (2019)

Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
por: Huang, Dong-Hui, et al.
Publicado: (2016)

High-sensitive cardiac troponin T
por: Xu, Ru-Yi, et al.
Publicado: (2013)

Cardiac Troponins in Dogs and Cats
por: Langhorn, R., et al.
Publicado: (2016)

The Evaluation of Cardiac Troponin T in Newborns
por: Tarkowska, Agata, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_47aqo294h5gcfavml9cj0q37qj